Lenvima, INN - lenvatinib - European Medicines Agency - Europa EU

pacienților adulți cu carcinom hepatocelular (un tip de cancer de ficat) care nu au fost tratați anterior cu un medicament împotriva cancerului administrat pe ...

Lenvima, INN - lenvatinib - European Medicines Agency - Europa EU - Zugehörige Dokumente

Lenvima, INN - lenvatinib - European Medicines Agency - Europa EU

https://www.ema.europa.eu/documents/overview/lenvima-epar-medicine-overview_ro.pdf

pacienților adulți cu carcinom hepatocelular (un tip de cancer de ficat) care nu au fost tratați anterior cu un medicament împotriva cancerului administrat pe ...

About us - NL - European Medicines Agency - Europa EU

https://www.ema.europa.eu/documents/other/about-us-european-medicines-agency-ema_nl.pdf

8 nov 2019 ... Leden van de raad van beheer . ... Het EMA wordt bestuurd door een onafhankelijke raad van beheer. De dagelijkse activiteiten van het.

Nobilis IB 4-91 - European Medicines Agency - Europa EU

https://www.ema.europa.eu/en/documents/product-information/nobilis-ib-4-91-epar-product-information_en.pdf

Special precautions for use in animals. Nobilis IB 4-91 is intended to protect chickens against respiratory signs of disease caused by IBV variant strain 4-91 only ...

Victoza - European Medicines Agency - Europa EU

https://www.ema.europa.eu/en/documents/overview/victoza-epar-summary-public_de.pdf

Victoza ist ein Arzneimittel, das bei Erwachsenen mit Typ 2-Diabetes zusätzlich zu Diät und körperlicher. Bewegung angewendet wird. Victoza wird angewendet: •.

Gardasil 9 - European Medicines Agency - Europa EU

https://www.ema.europa.eu/documents/product-information/gardasil-9-epar-product-information_en.pdf

1404. 4. 100.0 (-52.1,. 100.0). HPV 6-, 11-, 16-, or 18-related. AIN 2/3****. 194. 3. 208. 13. 74.9 (8.8, 95.4). *The PPE population consisted of individuals who ...

Vectra 3D - European Medicines Agency - Europa EU

https://www.ema.europa.eu/en/documents/product-information/vectra-3d-epar-product-information_en.pdf

Vectra 3D spot-on solution for dogs > 40 kg. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION. Active substances: Each ml contains 54 mg dinotefuran, ...

Syvazul BTV - European Medicines Agency - Europa EU

https://www.ema.europa.eu/documents/overview/syvazul-btv-epar-medicine-overview_es.pdf

9 Ene 2019 ... Syvazul BTV es una vacuna que se utiliza en ganado ovino y bovino, para ... La vacuna se presenta en forma de inyección y solo se podrá ...

Methylphenidate - European Medicines Agency - Europa EU

https://www.ema.europa.eu/documents/psusa/methylphenidate-list-nationally-authorised-medicinal-products-psusa/00002024/201810_en.pdf

25 Jun 2019 ... capsules, hard. DE/H/2223/003. PA1555/001/003. MEDICE ARZNEIMITTEL. PÜTTER GMBH & CO. KG. IE. Medikinet adult 40 mg Hartkapseln, ...

Pexion, imepitoin - European Medicines Agency - Europa EU

https://www.ema.europa.eu/documents/overview/pexion-epar-summary-public_de.pdf

Wie wirkt Pexion? Der Wirkstoff in Pexion, Imepitoin, ist ein Arzneimittel gegen Epilepsie. Epilepsie wird durch übermäßige elektrische Aktivität im Gehirn ...

Baraclude, INN-entecavir - European Medicines Agency - Europa EU

https://www.ema.europa.eu/en/documents/product-information/baraclude-epar-product-information_no.pdf

Bristol-Myers Squibb GmbH & Co. KGaA. Tel: 0800 0752002 ( 49 (0)89 121 42-350). Nederland. Bristol-Myers Squibb B.V.. Tel: 31 (0)30 300 2222. Eesti.

Nexavar, INN: sorafenib - European Medicines Agency - Europa EU

https://www.ema.europa.eu/documents/overview/nexavar-epar-summary-public_ro.pdf

carcinom hepatocelular (un tip de cancer hepatic);. • carcinom cu celule renale în stadiu avansat (un tip de cancer renal), când tratamentul anticanceros.

PUREVAX RCPCh - European Medicines Agency - Europa EU

https://www.ema.europa.eu/en/documents/product-information/purevax-rcpch-epar-product-information_en.pdf

Purevax RCPCh lyophilisate and solvent for suspension for injection. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION. Per dose of 1 ml: Lyophilisate:.

tetanus vaccines - European Medicines Agency - Europa EU

https://www.ema.europa.eu/en/documents/psusa/tetanus-vaccines-list-nationally-authorised-medicinal-products-psusa/00002910/201801_en.pdf

6 Sep 2018 ... TETAVAX injeksjonsvćske, suspensjon Vaksine mot tetanus (adsorbert) not available. 95-1156. SANOFI PASTEUR EUROPE. NO. TETAVAX ...

Assessment Report - European Medicines Agency - Europa EU

https://www.ema.europa.eu/documents/assessment-report/aflunov-epar-public-assessment-report_en.pdf

Serology Laboratory, Marburg, Germany, and SRH at the University of Siena, ... and eight in the Agrippal/AFLUNOV group) delivered a live-born baby. One of.

Truberzi, eluxadoline - European Medicines Agency - Europa EU

https://www.ema.europa.eu/en/documents/product-information/truberzi-epar-product-information_en.pdf

19 Sep 2016 ... For patients who are unable to tolerate the 200 mg daily dose (one 100 mg tablet, twice daily), the ... 64331 Weiterstadt, ... or you think you may be pregnant or are planning to have a baby, ask your doctor for advice before.

Exzolt, INN-Fluralaner - European Medicines Agency - Europa EU

https://www.ema.europa.eu/documents/overview/exzolt-epar-summary-public_en.pdf

Exzolt is a veterinary medicine used to treat poultry red mite (Dermanyssus gallinae) infestation in pullets (young female chickens), breeders and layer hens.

Movymia, INN-teriparatide - European Medicines Agency - europa.eu

https://www.ema.europa.eu/en/documents/overview/movymia-epar-summary-public_hr.pdf

Movymia je lijek koji se primjenjuje u liječenju osteoporoze (bolesti koja kosti čini ... Pagetova bolest, rak kostiju ili metastaze u kostima (rak koji se proširio na ...

Afinitor, INN-everolimus - European Medicines Agency - Europa EU

https://www.ema.europa.eu/documents/overview/afinitor-epar-summary-public_de.pdf

eingeleitet und überwacht werden, der Erfahrung in der Anwendung von Krebsarzneimitteln besitzt. Afinitor ist als Tabletten (2,5 mg, 5 mg und 10 mg) erhältlich; ...

Eliquis, INN-apixaban - European Medicines Agency - Europa EU

https://www.ema.europa.eu/en/documents/overview/eliquis-epar-summary-public_de.pdf

Eliquis ist ein Arzneimittel, das zur Vorbeugung venöser Thromboembolien (Blutgerinnsel in den. Venen) bei Erwachsenen nach Hüft- oder ...

Matricaria recutita - European Medicines Agency - Europa EU

https://www.ema.europa.eu/documents/herbal-references/final-list-references-supporting-assessment-matricaria-recutita-l-flos-matricaria-recutita-l_en-0.pdf

7. Juli 2015 ... Jablonska S, Rudzki E. Kamillosan® Konzentrat – ein nicht allergisierender Extrakt aus Kamille. Z Hautkr ... Wirkungsweise und Anwendungsformen der Kamille. ... Rossmann H, Patzelt-Wenczler R. Prüfung der Wirksamkeit, ...

Nexgard, afoxolaner - European Medicines Agency - Europa EU

https://www.ema.europa.eu/en/documents/overview/nexgard-epar-medicine-overview_de.pdf

Was ist NexGard und wofür wird es angewendet? NexGardist ein Arzneimittel zur Behandlung von Floh- und Zeckenbefall, Demodikose und Sarcoptes-. Räude ( ...

Levitra, INN-vardenafil - European Medicines Agency - Europa EU

https://www.ema.europa.eu/documents/overview/levitra-epar-summary-public_lt.pdf

Ją reikia suvartoti likus maždaug 25–60 minučių iki lytinio akto. Burnoje disperguojamosios tabletės neužgeriamos skysčiu. Jei Levitra plėvele dengtos tabletės.

Olysio, INN-simeprevir - European Medicines Agency - Europa EU

https://www.ema.europa.eu/en/documents/product-information/olysio-epar-product-information_en.pdf

The recommended dosage of OLYSIO is one capsule of 150 mg once daily, ... OLYSIO has no or negligible influence on the ability to drive and use machines.

Aldara; Imiquimod - European Medicines Agency - Europa EU

https://www.ema.europa.eu/documents/overview/aldara-epar-summary-public_de.pdf

Aldara ist eine Creme, die den Wirkstoff Imiquimod enthält. Es ist in Form von 250 mg-Beuteln erhältlich, die jeweils 12,5 mg Imiquimod (5 %) enthalten. ... verursachen, bzw. die anormalen Zellen in der Haut, die sich zu Hautkrebs oder ...

Xgeva, INN-denosumab - European Medicines Agency - Europa EU

https://www.ema.europa.eu/documents/overview/xgeva-epar-medicine-overview_hr.pdf

Te komplikacije uključuju frakture (prijelomi kostiju), kompresiju leđne moždine ... kosti koji se naziva gigantocelularni tumor kosti. Koristi se u bolesnika s ...

Lixiana; INN-edoxaban - European Medicines Agency - Europa EU

https://www.ema.europa.eu/documents/overview/lixiana-epar-summary-public_de.pdf

Dies ist eine Zusammenfassung des Europäischen Öffentlichen Beurteilungsberichts (EPAR) für Lixiana. Hierin wird erläutert, wie die Agentur das Arzneimittel ...

Mirataz, INN-mirtazapine - European Medicines Agency - Europa EU

https://www.ema.europa.eu/documents/overview/mirataz-epar-medicine-overview_de.pdf

Mirataz (Mirtazapin). EMA/687918/2019. Seite 2/3 durchschnittliche Gewichtszunahme nach 14 Tagen betrug etwa 130 g pro Katze und lag deutlich über.

CIALIS, INN - Tadalafil - European Medicines Agency - Europa EU

https://www.ema.europa.eu/documents/overview/cialis-epar-summary-public_et.pdf

mg ja 20 mg). Milleks Cialist kasutatakse? Cialist kasutatakse erektsioonihäirete (mida mõnikord nimetatakse impotentsuseks) raviks meestel, kui nad ei suuda ...

Leucogen, INN - FeLV - European Medicines Agency - Europa EU

https://www.ema.europa.eu/documents/overview/leucogen-epar-medicine-overview_en.pdf

Leucogen is a veterinary vaccine used in cats from eight weeks of age to protect them against feline leukaemia. Feline leukaemia is an infectious disease of cats ...

Valeriana officinalis - European Medicines Agency - Europa EU

https://www.ema.europa.eu/documents/herbal-references/final-list-references-supporting-assessment-valeriana-officinalis-l-radix-valeriana-officinalis-l_en.pdf

2 Feb 2016 ... Fachinetto R, Villarinho JG, Wagner C, Pereira RP, Avila DS, Burger ME et al. Valeriana ... Georg Olms Verlag, Hildesheim New York 1976.

Eylea, INN-Aflibercept - European Medicines Agency - Europa EU

https://www.ema.europa.eu/documents/overview/eylea-epar-medicine-overview_de.pdf

Die Fertigspritze enthält mehr als die empfohlene. Dosis; daher muss der Arzt bei der Vorbereitung der Injektion das überschüssige Volumen aus der. Spritze ...

Simparica, INN-sarolaner - European Medicines Agency - Europa EU

https://www.ema.europa.eu/en/documents/overview/simparica-epar-summary-public_de.pdf

189 Hunde mit Simparica behandelt, während 96 Hunde ein anderes ... Zeitraum sowie Tremor (Zittern), Ataxie (Unfähigkeit, die Körperbewegungen zu ...

Radicava, INN-edaravone - European Medicines Agency - Europa EU

https://www.ema.europa.eu/en/documents/withdrawal-report/withdrawal-assessment-report-radicava_en.pdf

24 May 2019 ... Requirements for Registration of Pharmaceuticals for Human Use. IND. IND. ISE ... The wording of 4.6 and 5.3 of the SmPC should be amended as indicated in the corresponding file. ... 5.3.5.2. Examine efficacy and safety of the free radical scavenger, ... specified before the code break of Study MCI186-17.

Vectra Felis - European Medicines Agency - Europa EU

https://www.ema.europa.eu/en/documents/product-information/vectra-felis-epar-product-information_en.pdf

Vectra Felis 423 mg/42.3 mg spot-on solution for cats. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION. Active substances: Each 0.9 ml spot-on applicator ...

MabThera, INN-rituximab - European Medicines Agency - Europa EU

https://www.ema.europa.eu/documents/variation-report/mabthera-h-c-165-ii-79-epar-assessment-report-variation_en.pdf

21 Mar 2013 ... In both GPA and MPA, vasculitis may be extended to other organs like the skin, nervous system (specifically vaso nervorum of peripheral nerves), ...

Cimicifuga racemosa - European Medicines Agency - Europa EU

https://www.ema.europa.eu/documents/herbal-references/draft-list-references-supporting-assessment-cimicifuga-racemosa-l-nutt-rhizome-revision-1_en.pdf

18 Jul 2017 ... Freudenstein J. Addendum to the 6-month oral toxicity study: ... Teschke R, Schwarzenboeck A, Schmidt-Taenzer W, Wolff A, Hennermann KH.